Aurora Biosynthetics

Aurora Biosynthetics is a state-of-the-art RNA manufacturing partner providing comprehensive, end-to-end solutions for the production of critical drug components, including plasmid DNA, mRNA, and lipid nanoparticles (LNPs). Located in Sydney, Australia, Aurora integrates process and analytical development, GMP manufacturing, and fill/finish services under one roof. This streamlined approach significantly reduces manufacturing risks and accelerates timelines, enabling biotechnology and pharmaceutical companies worldwide to rapidly advance their innovative RNA-based therapies. Leveraging strategic public-private partnerships and deep industry expertise, Aurora is uniquely positioned to address the growing global demand for reliable, high-quality RNA manufacturing solutions.